Logo image of SVRE

SAVERONE 2014 LTD -ADR (SVRE) Stock Fundamental Analysis

NASDAQ:SVRE - Nasdaq - US80516T1051 - ADR - Currency: USD

4.94  +0.47 (+10.51%)

After market: 4.76 -0.18 (-3.64%)

Fundamental Rating

2

SVRE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. SVRE has a bad profitability rating. Also its financial health evaluation is rather negative. SVRE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SVRE has reported negative net income.
In the past year SVRE has reported a negative cash flow from operations.
In the past 5 years SVRE always reported negative net income.
In the past 5 years SVRE always reported negative operating cash flow.
SVRE Yearly Net Income VS EBIT VS OCF VS FCFSVRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -146.86%, SVRE is doing worse than 95.83% of the companies in the same industry.
The Return On Equity of SVRE (-336.37%) is worse than 94.17% of its industry peers.
Industry RankSector Rank
ROA -146.86%
ROE -336.37%
ROIC N/A
ROA(3y)-113.03%
ROA(5y)-427.84%
ROE(3y)-211.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SVRE Yearly ROA, ROE, ROICSVRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K

1.3 Margins

With a Gross Margin value of 21.41%, SVRE is not doing good in the industry: 64.17% of the companies in the same industry are doing better.
SVRE's Gross Margin has improved in the last couple of years.
SVRE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.63%
GM growth 5YN/A
SVRE Yearly Profit, Operating, Gross MarginsSVRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K -10K

More info and screens

1

2. Health

2.1 Basic Checks

SVRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SVRE has been increased compared to 1 year ago.
The number of shares outstanding for SVRE has been increased compared to 5 years ago.
Compared to 1 year ago, SVRE has a worse debt to assets ratio.
SVRE Yearly Shares OutstandingSVRE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M
SVRE Yearly Total Debt VS Total AssetsSVRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

SVRE has an Altman-Z score of -6.77. This is a bad value and indicates that SVRE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.77, SVRE is doing worse than 89.17% of the companies in the same industry.
A Debt/Equity ratio of 0.49 indicates that SVRE is not too dependend on debt financing.
SVRE's Debt to Equity ratio of 0.49 is on the low side compared to the rest of the industry. SVRE is outperformed by 72.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z -6.77
ROIC/WACCN/A
WACC8.94%
SVRE Yearly LT Debt VS Equity VS FCFSVRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

A Current Ratio of 1.81 indicates that SVRE should not have too much problems paying its short term obligations.
The Current ratio of SVRE (1.81) is worse than 65.83% of its industry peers.
SVRE has a Quick Ratio of 1.28. This is a normal value and indicates that SVRE is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.28, SVRE is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.28
SVRE Yearly Current Assets VS Current LiabilitesSVRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

6

3. Growth

3.1 Past

SVRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.35%, which is quite impressive.
The Revenue for SVRE has decreased by -24.41% in the past year. This is quite bad
The Revenue has been growing by 104.94% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)43.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.75%
Revenue 1Y (TTM)-24.41%
Revenue growth 3Y104.94%
Revenue growth 5YN/A
Sales Q2Q%-67.25%

3.2 Future

SVRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.89% yearly.
SVRE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 88.54% yearly.
EPS Next Y66.38%
EPS Next 2Y36.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-31.97%
Revenue Next 2Y88.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SVRE Yearly Revenue VS EstimatesSVRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
SVRE Yearly EPS VS EstimatesSVRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SVRE. In the last year negative earnings were reported.
Also next year SVRE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SVRE Price Earnings VS Forward Price EarningsSVRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SVRE Per share dataSVRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as SVRE's earnings are expected to grow with 36.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.89%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SVRE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAVERONE 2014 LTD -ADR

NASDAQ:SVRE (2/28/2025, 8:16:26 PM)

After market: 4.76 -0.18 (-3.64%)

4.94

+0.47 (+10.51%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)09-20 2022-09-20/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change-93.79%
Ins Owners0.43%
Ins Owner ChangeN/A
Market Cap37.06M
Analysts82.86
Price TargetN/A
Short Float %1.1%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.15%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)34.85%
EPS NY rev (3m)-165.91%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 77.16
P/FCF N/A
P/OCF N/A
P/B 13.86
P/tB 13.86
EV/EBITDA N/A
EPS(TTM)-1.95
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-1.24
FCFYN/A
OCF(TTM)-1.24
OCFYN/A
SpS0.06
BVpS0.36
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -146.86%
ROE -336.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.41%
FCFM N/A
ROA(3y)-113.03%
ROA(5y)-427.84%
ROE(3y)-211.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.63%
GM growth 5YN/A
F-Score1
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14.16%
Cap/Sales 3.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 1.28
Altman-Z -6.77
F-Score1
WACC8.94%
ROIC/WACCN/A
Cap/Depr(3y)22.69%
Cap/Depr(5y)54.23%
Cap/Sales(3y)13.97%
Cap/Sales(5y)23.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.75%
EPS Next Y66.38%
EPS Next 2Y36.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.41%
Revenue growth 3Y104.94%
Revenue growth 5YN/A
Sales Q2Q%-67.25%
Revenue Next Year-31.97%
Revenue Next 2Y88.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-36.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.83%
OCF growth 3YN/A
OCF growth 5YN/A